Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ)
CNY 10.19
(10.04%)
CNY 10.19
(10.04%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 962.8 Million CNY | -34.16% |
| 2022 | 1.46 Billion CNY | -6.58% |
| 2021 | 1.56 Billion CNY | 33.47% |
| 2020 | 1.17 Billion CNY | -14.42% |
| 2019 | 1.37 Billion CNY | 36.31% |
| 2018 | 1 Billion CNY | 7.79% |
| 2017 | 932.77 Million CNY | 69.78% |
| 2016 | 549.39 Million CNY | -1.17% |
| 2015 | 555.89 Million CNY | -15.57% |
| 2014 | 658.41 Million CNY | 25.96% |
| 2013 | 522.71 Million CNY | 11.05% |
| 2012 | 470.69 Million CNY | 12.87% |
| 2011 | 417.01 Million CNY | 30.43% |
| 2010 | 319.72 Million CNY | 3.04% |
| 2009 | 310.29 Million CNY | -30.66% |
| 2008 | 447.48 Million CNY | 42.07% |
| 2007 | 314.98 Million CNY | 101.01% |
| 2006 | 156.7 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 229.17 Million CNY | 18.4% |
| 2024 Q1 | 193.55 Million CNY | 15.73% |
| 2024 Q3 | 192.89 Million CNY | -15.83% |
| 2023 Q1 | 311.16 Million CNY | -8.3% |
| 2023 Q2 | 267.27 Million CNY | -14.11% |
| 2023 Q3 | 224.38 Million CNY | -16.05% |
| 2023 FY | 962.8 Million CNY | -34.16% |
| 2023 Q4 | 167.24 Million CNY | -25.46% |
| 2022 Q2 | 414.69 Million CNY | 0.6% |
| 2022 Q3 | 296.21 Million CNY | -28.57% |
| 2022 Q4 | 339.32 Million CNY | 14.55% |
| 2022 Q1 | 412.2 Million CNY | -6.33% |
| 2022 FY | 1.46 Billion CNY | -6.58% |
| 2021 Q4 | 440.05 Million CNY | 6.49% |
| 2021 Q1 | 313.31 Million CNY | 11.32% |
| 2021 Q2 | 398.81 Million CNY | 27.29% |
| 2021 Q3 | 413.23 Million CNY | 3.62% |
| 2021 FY | 1.56 Billion CNY | 33.47% |
| 2020 FY | 1.17 Billion CNY | -14.42% |
| 2020 Q2 | 362.74 Million CNY | 65.96% |
| 2020 Q1 | 218.56 Million CNY | -39.36% |
| 2020 Q4 | 281.45 Million CNY | -9.24% |
| 2020 Q3 | 310.09 Million CNY | -14.51% |
| 2019 Q2 | 365.55 Million CNY | 30.9% |
| 2019 FY | 1.37 Billion CNY | 36.31% |
| 2019 Q4 | 360.43 Million CNY | -1.3% |
| 2019 Q3 | 365.19 Million CNY | -0.1% |
| 2019 Q1 | 279.26 Million CNY | 0.67% |
| 2018 Q3 | 221.05 Million CNY | -20.76% |
| 2018 FY | 1 Billion CNY | 7.79% |
| 2018 Q1 | 227.97 Million CNY | -20.75% |
| 2018 Q2 | 278.97 Million CNY | 22.37% |
| 2018 Q4 | 277.39 Million CNY | 25.49% |
| 2017 Q2 | 249.75 Million CNY | 39.77% |
| 2017 Q1 | 178.68 Million CNY | 47.75% |
| 2017 FY | 932.77 Million CNY | 69.78% |
| 2017 Q4 | 287.64 Million CNY | 32.75% |
| 2017 Q3 | 216.68 Million CNY | -13.24% |
| 2016 FY | 549.39 Million CNY | -1.17% |
| 2016 Q4 | 120.93 Million CNY | -12.9% |
| 2016 Q3 | 138.84 Million CNY | -18.44% |
| 2016 Q2 | 170.23 Million CNY | 39.91% |
| 2016 Q1 | 121.67 Million CNY | -12.26% |
| 2015 Q2 | 164.95 Million CNY | 21.19% |
| 2015 Q1 | 136.11 Million CNY | -24.8% |
| 2015 Q3 | 116.14 Million CNY | -29.59% |
| 2015 FY | 555.89 Million CNY | -15.57% |
| 2015 Q4 | 138.67 Million CNY | 19.4% |
| 2014 Q2 | 145.61 Million CNY | 9.25% |
| 2014 Q1 | 133.28 Million CNY | 14.22% |
| 2014 FY | 658.41 Million CNY | 25.96% |
| 2014 Q4 | 181 Million CNY | -8.82% |
| 2014 Q3 | 198.51 Million CNY | 36.32% |
| 2013 FY | 522.71 Million CNY | 11.05% |
| 2013 Q4 | 116.68 Million CNY | -29.85% |
| 2013 Q2 | 119.11 Million CNY | -1.22% |
| 2013 Q3 | 166.33 Million CNY | 39.64% |
| 2013 Q1 | 120.58 Million CNY | -11.28% |
| 2012 FY | 470.69 Million CNY | 12.87% |
| 2012 Q2 | 112.01 Million CNY | 9.15% |
| 2012 Q3 | 120.13 Million CNY | 7.25% |
| 2012 Q4 | 135.91 Million CNY | 13.13% |
| 2012 Q1 | 102.62 Million CNY | 3.31% |
| 2011 Q3 | 108.28 Million CNY | -20.47% |
| 2011 Q2 | 136.14 Million CNY | 85.88% |
| 2011 Q1 | 73.24 Million CNY | -17.09% |
| 2011 FY | 417.01 Million CNY | 30.43% |
| 2011 Q4 | 99.33 Million CNY | -8.26% |
| 2010 Q4 | 88.34 Million CNY | 18.43% |
| 2010 FY | 319.72 Million CNY | 3.04% |
| 2010 Q3 | 74.59 Million CNY | 15.72% |
| 2010 Q2 | 64.45 Million CNY | -30.19% |
| 2010 Q1 | 92.33 Million CNY | 7.84% |
| 2009 Q1 | 71.04 Million CNY | 0.0% |
| 2009 Q3 | 75.92 Million CNY | -2.29% |
| 2009 Q2 | 77.7 Million CNY | 9.37% |
| 2009 Q4 | 85.62 Million CNY | 12.77% |
| 2009 FY | 310.29 Million CNY | -30.66% |
| 2008 FY | 447.48 Million CNY | 42.07% |
| 2007 FY | 314.98 Million CNY | 101.01% |
| 2006 FY | 156.7 Million CNY | 0.0% |